به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت
فهرست مطالب نویسنده:

zahra eslamifar

  • مهین بهزادی فرد*، زهرا اسلامی فر، یاسین آریا نژاد، نوشین اسد مسجدی، بهنام عزیزاللهی، مازیار حیدری
    مقدمه

    عوامل فراوانی ازجمله اختلالات انعقادی بر روی مرگ ومیر در مبتلایان به عفونت ویروسی کووید-19 تاثیرگذار است. با توجه به اهمیت اختلالات انعقادی در این بیماری، هدف از این مطالعه گذشته نگر بررسی ارتباط سن، جنس، نتایج آزمایش های انعقادی شامل زمان پروترومبین (PT)، زمان نسبی ترومبوپلاستین (PTT)، دی دایمر (D-dimer) و شمارش پلاکت (PLT) و ارتباط این مولفه ها با میزان مرگ ومیر در بیماران کووید-19 بخش مراقبت های ویژه بیمارستان گنجویان دزفول بود.

    مواد و روش ها

    در این مطالعه توصیفی مبتنی بر اطلاعات پرونده های بیمارستانی سال 1399، 100 بیمار کووید-19 بستری شده در بخش مراقبت های ویژه بیمارستان گنجویان دزفول بررسی شدند که آزمایش تاییدشده مولکولی ویروس کرونای جدید و نتایج شاخص های انعقادی ذکرشده داشتند و بدون سابقه بیماری های قلبی عروقی بودند. اطلاعات به دست آمده از این پژوهش با استفاده از نرم افزار آماری Graph pad Prism vol.8.3 تجزیه وتحلیل شد. متغیرهای کیفی با استفاده از شاخص های فراوانی، درصد فراوانی و فراوانی نسبی توصیف گردیدند؛ همچنین از آزمونt-test  برای مقایسه معناداری مولفه های مطالعه میان گروه فوت و ترخیص استفاده شد.

    یافته های پژوهش: 

    سن بیماران بین 30 تا 85 سال و میانگین آن 2/14±2/58 بود. میانگین سن در بیماران فوت شده (07/11±85/64) سال و بیشتر از بیماران ترخیص یافته (9/13±6/58) بود. نتایج آزمون تی تفاوت معنی داری را میان سن این دو گروه نشان داد (P<0.05). نتایج تست های دی دایمر و PT در بیماران مبتلا به کووید-19 که فوت شدند، به صورت معنی داری بیشتر از بیماران ترخیص شده بود، درحالی که مقایسه شمارش پلاکت و PTT میان دو گروه فوتی و ترخیص تفاوت معناداری را نشان نداد (P<0.05).

    بحث و نتیجه گیری

    با توجه به نتایج این بررسی، توجه به نتایج تست های دی دایمر و PT ممکن است در پیش بینی پیش آگهی بیماری کووید-19 کمک کننده باشد.

    کلید واژگان: کووید-19, دی دایمر, ویروس سارس کرونا 2, ویروس سارس کرونای جدید, زمان پروترومبین, زمان نسبی ترومبوپلاستین, شمارش پلاکت, بخش مراقبت های ویژه, ای سی یو
    Mahin Behzadifard*, Zahra Eslamifar, Yasin Arianezhad, Nooshin Asadmasjedi, Behnam Azizolahi, Maziyar Heydari
    Introduction

     Many factors, including coagulation disorders, have an effect on mortality in patients with Covid-19 viral infection. Considering coagulation problems are so important for these patients, the goal of this study was to look into the connection between coagulation test results, such as prothrombin time (PT), partial thromboplastin time (PTT), D-dimer, and platelet count, and the death rate in Covid-19 patients who were admitted to the intensive care unit of Ganjovian Hospital (Dezful, Iran) in 2020.

    Materials & Methods

    This comprehensive cross-sectional study was conducted on the information of 100 patients with Covid-19 hospitalized in the intensive care unit. The data from the patient’s files were analyzed using Graph Pad Prism version 8.3 statistical software. Qualitative variables were described using frequency indices, percentages, and relative frequency. A t-test was also used to compare the study parameters between the death and discharge groups. The level of significance was considered less than 0.05.

    Results

    The mean and standard deviation of the age were 58.2±14.2. The average age of the death group was significantly higher than that of discharged patients (P=0.038). The D-dimer and PT test results in patients with Covid-19 who died were significantly higher than those of discharged patients (P=0.002), but there was no significant difference in platelet count and PTT between the two groups (P=0.680).

    Conclusion

    According to the results of this study, paying attention to the results of D-dimer and PT tests may be helpful in predicting the prognosis of Covid-19 disease.

    Keywords: Covid-19, SARS-Cov-2, Nsars-Cov-2, D-Dimer, Prothrombin Time, Relative Thromboplastin Time, Platelet Count, Intensive Care Unit, ICU
  • ‎Zahra Eslamifar*, ‎Morteza Habibi Moghadam ‎, Leila Jafaripour
    Background

    Silymarin is utilized in the treatment of liver conditions primarily because of its antioxidant properties and its ability to lower blood lipid levels. Propofol, an anesthetic and antioxidant, is harmful to patients with hyperlipidemia. The aim of this study was to investigate the beneficial effects of silymarin and propofol on liver enzymes and blood indices. We also studied the impacts of propofol and silymarin on propofol-induced hyperlipidemia in male Wistar rats.

    Methods

    The rats were divided into four groups: 1) controls; 2) silymarin; 3) propofol; and, 4) combined propofol and silymarin. On the 22nd day after the treatments, all rats were anesthetized, and their blood samples were collected to estimate the levels of AST, ALT, ALP, LDH, TG, TC, LDL-C, and HDL-C. After being sacrificed, the liver was removed from each rat to determine the levels of MDA, GPx, GSH, and CAT. Moreover, histopathological examinations were performed on all liver samples.

    Results

    Silymarin and propofol, used either separately or in combination, had a favorable effect on the indicators of oxidative stress and the liver’s antioxidant markers. The propofol treatment alone significantly increased the blood lipid parameters. The administration of Silymarin had a modulating effect on propofol-induced hyperlipidemia in rats.

    Conclusion

    Propofol and silymarin had favorable effects on the liver; however, propofol increased the blood lipids due to its lipid structure, which is a warning for patients with hyperlipidemia. In this regard, silymarin may be considered a protective option, making it a potential treatment for patients experiencing hyperlipidemia induced by propofol.

    Keywords: Hyperlipidemia, Liver Antioxidant Factors, Liver Enzymes, Male Wistar Rats, Propofol, Silymarin
  • Susan Sabbagh *, Zahra Eslamifar, Mehdi Goudarzi, Ali Ebrahimzadeh
    Background

    Gastrointestinal (GI) mucositis is one of the serious side effects of methotrexate (MTX) treatment. It is known that oxidative stress plays an important role in drug-induced side effects.

    Objectives

    The present study aimed to assess the effect of gallic acid (GA) against MTX-induced intestinal mucositis in male Wistar rats.

    Methods

    Twenty-eight adult male Wistar rats were randomly divided into 4 groups (n = 7), including (1) control group; (2) GA group (gallic acid: 30 mg/kg/day, orally); (3) MTX group [20 mg/kg, intra peritoneal (IP)]; and (4) (MTX + GA) group (MTX: 20 mg/kg, IP and gallic acid: 30 mg/kg/day, orally). Then amounts of malondialdehyde (MDA), nitric oxide (NO), glutathione peroxidase (GPx), glutathione (GSH), superoxide dismutase (SOD), interleukin 2 (IL-2) and interleukin 6 (IL-6) were analyzed in serum samples and then the histopathological examinations of the duodenum and jejunum of animals groups.

    Results

    The results showed that treatment with GA significantly reduced the MTX-induced elevation of serumMDA(P < 0.001), NO (P < 0.001), IL-2 (P < 0.001) and IL-6 (P < 0.001) contents and increased MTX-induced reduction in GSH (P < 0.001) content, GPx (P < 0.001) and SOD (P < 0.001) activity. In addition, the histopathological results showed that MTX leads to intestinal tissue damage, and gallic acid can remarkably improve the pathological changes.

    Conclusions

    Our results indicate that gallic acid can mitigate oxidative stress and pro-inflammatory parameters and also moderately prevent histopathological damage of the small intestine of rats exposed to MTX.

    Keywords: Methotrexate, Intestinal Mucositis, Gallic Acid, Oxidative Stress, Pro-inflammatory Cytokines, Histopathology
  • Rahmatollah Jowkar, Zahra Eslamifar, Mokhtar Esmaeilnejad Ganji, Khadijeh Ezoji, Ali Bijani, Shahram Seyfi*
    Background

    Low back pain (LBP) is one of the most common complications after lower limb orthopedic surgery, which leads to many significant limitations and problems for patients and society. The aim of the present study was to investigate LBP incidence rate following general anesthesia (GA) and spinal anesthesia (SA) in lower limb orthopedic surgery.

    Methods

    In this randomized clinical trial study, all patients who were candidates for elective orthopedic surgery referred to Shahid Beheshti Hospital in Babol, entered the study with informed consent.
    Patients were divided into two groups and LBP incidence rate following spinal anesthesia and general anesthesia was evaluated.

    Results

    Out of 110 patients, 46 (41.8%) complained of LBP as a postoperative complication and 64 cases (58.2%) did not report it. The mean pain decreased over time in patients with LBP. Results also showed that LBP intensity was higher in spinal anesthesia group one day and one week after surgery. One month after surgery, the general anesthesia group did not report LBP, but the spinal anesthesia group still complained of LBP. There was no significant relationship between sex, age, BMI, duration of surgery, type of surgery and cause of fracture with LBP incidence.

    Conclusion

    According to the present study, the mean LBP intensity in the general anesthesia group is significantly less than spinal anesthesia group one day, one week and one month after surgery. patients should receive necessary explanations about the complications of both types of anesthesia preoperatively so that they consciously choose the method of anesthesia.

    Keywords: Low back pain, Spinal anesthesia, General anesthesia, complications
  • Zahra Eslamifar, Javad Moazen, Hossein Tizgar, Fatemeh Pourmotahari, Mahin Behzadifard *
    Background

    Areas with a higher prevalence of vitaminDdeficiency have reported a higher frequency of severe coronavirus disease 2019 (COVID-19) infections.

    Objectives

    This study aimed to assess the possible association between vitamin D and COVID-19.

    Methods

    This study examined the vitamin D status, hepatic, serologic, and hematologic parameters of COVID-19 patients who tested positive upon admission to a major referral center in southwest Iran. A total of 50 cases and 50 controls were enrolled in the study after obtaining informed consent. The patients did not receive a vitamin D supplement during their hospitalization.

    Results

    Patients with insufficiency and deficiency of vitamin D3 had a longer hospitalization time, a higher likelihood of ICU admission, and a greater risk of death compared to cases with sufficient levels of vitamin D.

    Conclusions

    The results of this study showed that vitamin D deficiency is associated with increased severity and mortality rates. Therefore, using a vitamin D supplement may help reduce the severity of COVID-19.

    Keywords: Vitamin D, SARS-CoV-2, COVID-19, RT-PCR
  • Sobhan Rahimi Monfared, Ali Valibeik, Leila Jafaripour, Zahra Eslamifar, Saeid Veiskarami, Hassan Ahmadvand *
    Objective (s)

    Gentamicin leads to kidney failure by producing free radicals and inflammation in renal tissue. Cineole as a terpenoid has antioxidant properties. Antioxidants can play an effective role in preserving the oxidant-antioxidant balance. Hence, this study investigated the effects of cineole on acute kidney injury (AKI) and renal function recovery following gentamicin administration in rats.

    Materials and Methods

    36 male Wistar rats were randomly divided into 6 equal groups; healthy control, gentamicin, DMSO carriers, cineole 50, cineole 100, and vitamin E. After 12 days of treatment, the animals were anesthetized with ketamine and xylazine. Serum and kidney samples were taken for biochemical and gene expression experiments.

    Results

    Cineole 50 and 100 groups increased the levels of serum glutathione (GSH) (<0.05), kidney and serum glutathione peroxidase (GPX) (<0.001), kidney catalase (CAT) (<0.001), serum nitric oxide (NO) (<0.001), and the GPX gene (<0.05) compared with the gentamicin group. These treatment groups had decreased levels of kidney malondialdehyde (MDA) (<0.001), serum creatinine (<0.001), urine protein, and the Interleukin 6 (IL-6) gene (<0.05) compared with the gentamicin group. Cineole 50 increased the serum MDA (<0.001), urea, and CAT gene (>0.05) and decreased the kidney GSH (<0.05) and the tumor necrosis factor-alpha (TNF-α) gene (<0.05). Cineole 100 increased the kidney GSH (<0.05) and decreased the serum MDA (<0.001), urea, CAT gene (>0.05), and TNF-α gene (>0.05) compared with the gentamicin group. Improvement in histological alterations was displayed in cineole groups compared with the gentamicin group.

    Conclusion

    Cineole can reduce kidney damage caused by nephrotoxicity following gentamicin consumption through its antioxidant and anti-inflammatory properties.

    Keywords: Cineole, Gentamicin, Nephrotoxicity, Oxidative stress, Rat
  • سارا پورمحمدی دزفولیان، سوسن صباغ، مرتضی حبیبی مقدم، زهرا اسلامی فر*
    مقدمه

    متوترکسات (Methotrexate: MTX) یک داروی سیتوتوکسیک است که در برابر برخی بیماری‌ها و تومورها تجویز می‌شود که کاربرد آن به‌دلیل برخی عوارض جانبی محدود شده است. پروپوفول یک داروی با خاصیت آنتی‌اکسیدانی یکی از داروهای آرام‌بخشی و بیهوشی مطلوب می‌باشد. هدف این مطالعه ارزیابی اثر پروپوفول در برابر سمیت کبدی ناشی از متوترکسات می‌باشد.

    مواد و روش‌ها

    تعداد 24 رت به 4 گروه تقسیم شدند: گروه کنترل (گاواژ آب مقطر) گروه پروپوفول (10 mg/kg سه بار در هفته) گروه متوترکسات (20 mg/kg در روزهای17 و 18) و گروه پروپوفول-متوترکسات. تزریقات درون صفاقی و مدت مطالعه 21 روز بود. سپس تمام موش‌ها بیهوش شدند و پلاسما برای تخمین آسپارتات آمینوترانسفراز (Aspartate aminotransferase: AST)، آلانین آمینوترانسفراز (Alanine aminotransferase: ALT) و لاکتات دهیدروژناز (Lactate dehydrogenase: LDH) و همچنین بیلیروبین توتال جمع‌آوری شد. بافت کبد جهت مطالعه شاخص‌های هیستوپاتولوژیک جداسازی شد.

    نتایج

    در مقایسه گروه MTX با گروه pro-MTX مشاهده شد پروپوفول به‌طور معنی‌داری موجب کاهش سطح آنزیم‌های AST و ALT شد (0001/0<P) اما اثر آن بر کاهش ALP و LDH معنی‌دار نبود. تغییرات بیلیروبین توتال بر هیچ گروهی معنی‌دار نبود. در بررسی تغییرات هیستوپاتولوژیک کبدی، در گروه MTX، نکروز سلولی، دژنراسیون سلولی، ارتشاح لکوسیت‌ها، پرخونی ورید مرکزی و اتساع سینوزوییدها دیده شد. آسیب در گروه pro-MTX در برابر گروه MTX به شکل معنی‌داری کاهش یافت (0001/0<P).

    نتیجه‌گیری

    نتایج تحقیق حاضر نشان داد که پروپوفول در برابر سمیت کبدی ناشی از متوترکسات اثرات محافظتی دارد، اما برای کاربرد بالینی، مطالعات بیشتری موردنیاز است.

    کلید واژگان: متوترکسات, پروپوفول, هپاتوتوکسیستی, هیستوپاتولوژی, آنزیم های کبدی
    Sara Pour Mohammadi, Susan Sabbagh, Morteza Habibi Moghadam, Zahra Eslamifar*
    Introduction

    Methotrexate (MTX) is a cytotoxic drug that is prescribed for some diseases and tumors that its use is limited due to some side effects. Propofol, a drug with antioxidant properties, is one of the most desirable sedatives and anesthetics. The aim of this study was to evaluate the effect of propofol against MTX-induced hepatotoxicity.

    Methods

    24 rats were divided into 4 groups: control group (distilled water gavage), propofol group (10 mg / kg three times a week), methotrexate group (20 mg/kg on days 17 and 18) and propofol-methotrexate group. There were intraperitoneal injections and the duration of the study was 21 days. Animals were anesthetized and plasma was collected to estimate AST, ALT, LDH, and total bilirubin. Liver tissue was isolated for histopathological study.

    Results

    There was observed that propofol significantly reduced the levels of AST and ALT (P<0.0001), but its effect on reducing ALP and LDH was not significant. Changes in total bilirubin were not significant in any group. In the histopathological study, in "MTX group" were seen cell necrosis, cell degeneration, leukocyte infiltration, congestion of central vein and sinusoid dilation. Injury was significantly reduced in the "pro-MTX group" compared to the "MTX group"(P<0.0001).

    Conclusion

    The results of the present study showed that propofol has protective effects against methotrexate-induced hepatotoxicity, but for clinical application, there are needed further studies.

    Keywords: Methotrexate, Propofol, Hepatotoxicity, Histopathology, liver enzymes
سامانه نویسندگان
  • دکتر زهرا اسلامی فر
    دکتر زهرا اسلامی فر
    استادیار پیراپزشکی، دانشگاه علوم پزشکی دزفول، دزفول، ایران
اطلاعات نویسنده(گان) توسط ایشان ثبت و تکمیل شده‌است. برای مشاهده مشخصات و فهرست همه مطالب، صفحه رزومه ایشان را ببینید.
بدانید!
  • در این صفحه نام مورد نظر در اسامی نویسندگان مقالات جستجو می‌شود. ممکن است نتایج شامل مطالب نویسندگان هم نام و حتی در رشته‌های مختلف باشد.
  • همه مقالات ترجمه فارسی یا انگلیسی ندارند پس ممکن است مقالاتی باشند که نام نویسنده مورد نظر شما به صورت معادل فارسی یا انگلیسی آن درج شده باشد. در صفحه جستجوی پیشرفته می‌توانید همزمان نام فارسی و انگلیسی نویسنده را درج نمایید.
  • در صورتی که می‌خواهید جستجو را با شرایط متفاوت تکرار کنید به صفحه جستجوی پیشرفته مطالب نشریات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال